Study
Large multicenter study found no cognitive advantage from vitamin B12 supplementation in older adults without deficiency.
In plain language
A public health analysis examining the relationship between vitamin B12 supplementation and Alzheimer's disease or dementia risk, evaluating population-level evidence and guidelines for cognitive health maintenance in aging adults.
Use the full description to understand the study design, methods, and the limits of the findings.
A population-based study published in Alzheimer's & Dementia found no consistent cognitive benefit from vitamin B12 supplementation among non-deficient older adults. Results align with previous meta-analyses showing limited preventive effect for dementia.
Open the original publication for the complete methods, outcomes, and source material.
Published December 2025
Opens at the publisher · external site · may require institutional access
The study provides a comprehensive analysis of vitamin B12 supplementation and cognitive outcomes in older adults. While it lacks the control of an RCT, it offers valuable population-level insights. The methodology is transparent and aligns with existing research, though the non-significant findings limit the strength of its conclusions. Overall, it is a credible study with minor limitations, particularly relevant to the senior demographic.
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 6.5/10 | |
| Bias & Methods | 6.0/10 | |
| Statistical Integrity | 7.0/10 | |
| Transparency | 8.0/10 | |
| Conflict of Interest Disclosure | 9.0/10 | |
| Replication / External Validation | 7.0/10 | |
| Relevance to Seniors | 9.0/10 | |
| Journal Quality | 8.0/10 |
The study's alignment with previous meta-analyses adds credibility, but the lack of direct replication studies and the inherent limitations of a non-RCT design should be considered when interpreting the results.
Build a personalized plan using research-backed studies, conditions, and treatments.